Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Inhaled insulin: overview of a novel route of insulin administration Mastrandrea LDVasc Health Risk Manag 2010[Mar]; 6 (ä): 47-58Diabetes is a chronic disease characterized by inadequate insulin secretion with resulting hyperglycemia. Diabetes complications include both microvascular and macrovascular disease, both of which are affected by optimal diabetes control. Many individuals with diabetes rely on subcutaneous insulin administration by injection or continuous infusion to control glucose levels. Novel routes of insulin administration are an area of interest in the diabetes field, given that insulin injection therapy is burdensome for many patients. This review will discuss pulmonary delivery of insulin via inhalation. The safety of inhaled insulin as well as the efficacy in comparison to subcutaneous insulin in the various populations with diabetes are covered. In addition, the experience and pitfalls that face the development and marketing of inhaled insulin are discussed.|Administration, Inhalation[MESH]|Diabetes Mellitus, Type 1/*drug therapy/metabolism[MESH]|Diabetes Mellitus, Type 2/*drug therapy/metabolism[MESH]|Glucose/administration & dosage[MESH]|Humans[MESH]|Hypoglycemic Agents/*administration & dosage/adverse effects/pharmacokinetics[MESH]|Insulin/*administration & dosage/adverse effects/pharmacokinetics[MESH]|Lung/*metabolism[MESH]|Medication Adherence[MESH]|Respiration Disorders/metabolism[MESH]|Smoking/adverse effects[MESH] |